Olympus Corp
OLY1
Company Profile
Business description
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
Contact
2951 Ishikawacho
Hachioji192-8507
JPNT: +81 333402111
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2027
Employees
27,634
Stocks News & Analysis
stocks
Earnings margins to improve for mining specialist
Premium products drive margins yet shares fully valued.
stocks
Nvidia: Hugging Face acquisition both a wise offensive and defensive move
We think this improves Nvidia’s position within the open-source community.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,200.60 | 12.10 | -0.13% |
| CAC 40 | 8,282.13 | 3.36 | 0.04% |
| DAX 40 | 25,933.32 | 113.08 | -0.43% |
| Dow JONES (US) | 53,414.25 | 271.86 | -0.51% |
| FTSE 100 | 10,844.06 | 12.97 | 0.12% |
| HKSE | 25,413.12 | 237.75 | -0.93% |
| NASDAQ | 26,506.99 | 77.07 | -0.29% |
| Nikkei 225 | 66,399.84 | 1,378.90 | 2.12% |
| NZX 50 Index | 13,942.83 | 31.35 | -0.22% |
| S&P 500 | 7,718.60 | 29.11 | -0.38% |
| S&P/ASX 200 | 9,010.90 | 12.50 | -0.14% |
| SSE Composite Index | 3,932.70 | 2.58 | 0.07% |